| NDC Code: |
47335-082 |
| Proprietary Name: |
LIPODOX |
| Suffix: |
|
| Non-Proprietary Name: |
Doxorubicin Hydrochloride |
| Dosage Form: |
INJECTABLE, LIPOSOMAL |
| Method: |
INTRAVENOUS |
| Original Marketing Date: |
09-02-2012 |
| Category Name: |
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Application Number: |
|
| Labeler: |
SUN PHARMA GLOBAL FZE |
| Substance Name: |
DOXORUBICIN HYDROCHLORIDE |
| Active Numerator Strength: |
2 |
| Active Ingredient Unit: |
mg/mL |
| Pharm Classes: |
Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
| DEA Schedule: |
|
